Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Hua Xi Kou Qiang Yi Xue Za Zhi ; 25(5): 441-3, 2007 Oct.
Artigo em Chinês | MEDLINE | ID: mdl-18072554

RESUMO

OBJECTIVE: To study the influence of thermochemotherapy on the activity of cytotoxic T lymphocyte (CTL) in peripheral blood of patients with oral maxillofacial cancer. METHODS: Twenty-one subjects with oral maxillofacial cancer were treated by thermochemotherapy, and the activity of CTL in peripheral blood was analyzed. RESULTS: Thermochemotherapy can obviously enhance the activity of CTL (P<0.01). CONCLUSION: Thermochemotherapy can enhance the activity of CTL, thus enhance the patient's immune function. Therefore, it can enhance the antitumor response in whole body.


Assuntos
Neoplasias Bucais/tratamento farmacológico , Linfócitos T Citotóxicos , Humanos , Hipertermia Induzida
2.
Hua Xi Kou Qiang Yi Xue Za Zhi ; 22(4): 267-70, 2004 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-15379301

RESUMO

OBJECTIVE: To study the effect of angiogenesis inhibitor and its combine with chemical drug in suppressing the growth of adenoid cystic carcinoma (ACC). METHODS: Acc-M cells were inoculated subcutaneous into BABL/C nu/nu mice. The mice were divided into control, different dose of TNP-470 treatment groups, 5-Fu treatment group and TNP-470 plus 5-Fu treatment group. Treatments were given 48 hours after inoculation. The mice were sacrificed on the 22nd day and excised tumors were weighted. Tumors were also investigated by immunohistochemistry and ultrastructural observations. RESULTS: TNP-470 100 mg/kg/qod efficiently inhibited the growth of Acc-M tumors. TNP-470 30 mg/kg/qod combined with 50 mg/kg/week 5-Fu also resulted in significant growth inhibit of the tumors. TNP-470 suppressed tumor growth by inhibiting neovascularization, therefore inducing apoptosis of Acc-M cells. All experimental groups had different degrees of VEGF and bFGF express. CONCLUSION: Since ACC is a slow developing tumor, blood supply is not so sufficient as sarcomas. Angiogensis inhibitor may inhibit its growth in high dosage. Combining medium dosage of angiogensis inhibitor with chemical drug may have synergistic result in inhibiting ACC growth.


Assuntos
Inibidores da Angiogênese/farmacologia , Carcinoma Adenoide Cístico/tratamento farmacológico , Cicloexanos/farmacologia , Fluoruracila/farmacologia , Sesquiterpenos/farmacologia , Animais , Apoptose , Linhagem Celular Tumoral , Humanos , Camundongos Endogâmicos BALB C , Camundongos Nus , O-(Cloroacetilcarbamoil)fumagilol
3.
Hua Xi Kou Qiang Yi Xue Za Zhi ; 21(2): 127-9, 2003 Apr 20.
Artigo em Chinês | MEDLINE | ID: mdl-12838699

RESUMO

OBJECTIVE: The purpose of this study was investigate the effect of hyperthemia on multidrug resistance in K562/ADM cell. METHODS: The MDR1 (mulitdrug resistance gene) and MRP (multidrug resistant associated gene) gene expressions in Tca8113 and K562/ADM cell lines were analyzed by RT-PCR after treated with different cytotoxic drugs and different temperature (37 degrees C and 41 degrees C). The function and expression of Pgp and MRP were detected by fluorescence photometeric assays. RESULTS: Inhibition rate of both cells was significantly enhanced by exposure to chemotherapeutic drugs and 41 degrees C temperature; Exposing to 41 degrees C hyperthemia reduced MDR1 and MRP expression and enhanced intracellular drug concentration as well in K562/ADM. CONCLUSION: 41 degrees C hyperthemia could effectively enhance the inhibition rate of chemotherapeutic drugs and partially reverse the multidrug resistance. It is suggested that hyperthemia could be used as a method to overcome multidrug resistance.


Assuntos
Antineoplásicos/farmacologia , Bleomicina/análogos & derivados , Resistencia a Medicamentos Antineoplásicos/genética , Genes MDR/genética , Hipertermia Induzida , Proteínas Associadas à Resistência a Múltiplos Medicamentos/biossíntese , Neoplasias da Língua/patologia , Bleomicina/farmacologia , Cisplatino/farmacologia , Resistência a Múltiplos Medicamentos , Humanos , Células K562 , Metotrexato/farmacologia , Proteínas Associadas à Resistência a Múltiplos Medicamentos/genética , Neoplasias da Língua/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA